← Eichor
Study identifier: NCT05801861 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Modulating Goal-directed Navigation Using Noninvasive Brain Stimulation

Condition: Spatial Navigation  ·  Sponsor: Rutgers, The State University of New Jersey

PhaseNA
Planned participants60
Who can joinAll sexes, 18 Years to 55 Years
Healthy volunteersYes

About this study

Our specific aim is to examine the effects of TMS on spatial processing during goal-directed navigation. In these experiments the investigators will utilize a scalp-recorded brain oscillation called right posterior theta that is believed to index the sensitivity of the parahippocampal cortex to spatial context. Here the investigators will asked whether this electrophysiological signal can be modulated up or down using TMS while participants engage in virtual navigation tasks, and if so, whether it would affect the spatial encoding of rewards and subsequent choices during task performance.

This description comes directly from the study's public registry record.

Talk to the study team

Travis E Baker, PhD  ·  973-353-5485  ·  travis.e.baker@rutgers.edu

Malte Gueth  ·  973-353-3509  ·  mrg217@newark.rutgers.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Rutgers University - NewarkNewark, New Jersey, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05801861